By Sandra Silvestri, EVP & Chief Medical Officer, Ipsen In today’s rapidly evolving treatment landscape the approval of a medicine
By Sandra Silvestri, EVP & Chief Medical Officer, Ipsen In today’s rapidly evolving treatment landscape the approval of a medicine
ALLSC-GB-001481 July 2026